SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-050027
Filing Date
2024-04-22
Accepted
2024-04-22 16:31:58
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 tm2412099-1_s3.htm S-3 487460
2 EXHIBIT 5.1 tm2412099d2_ex5-1.htm EX-5.1 30118
3 EXHIBIT 23.1 tm2412099d2_ex23-1.htm EX-23.1 5156
4 EX-FILING FEES tm2412099d2_ex-filingfees.htm EX-FILING FEES 35820
5 GRAPHIC lg_jaguarhealth-4c.jpg GRAPHIC 33855
6 GRAPHIC tm2412099d2_ex5-1img001.jpg GRAPHIC 3472
7 GRAPHIC tm2412099d2_ex5-1img002.jpg GRAPHIC 1901
8 GRAPHIC tm2412099d2_ex23-1img001.jpg GRAPHIC 4964
  Complete submission text file 0001104659-24-050027.txt   621179
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278861 | Film No.: 24861585
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)